In reply: Treatment of cachexia: An overview of recent developments

Affiliations

¹ Division of Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany; Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. Electronic address: stephan.von.haehling@web.de.
² Division of Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany.

Comment

Stephan von Haehling et al. Int J Cardiol. 2015.

. 2015 Dec 15:201:424.

doi: 10.1016/j.ijcard.2015.08.012. Epub 2015 Aug 5.

¹ Division of Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany; Applied Cachexia Research, Department of Cardiology, Charité Medical School, Campus Virchow-Klinikum, Berlin, Germany. Electronic address: stephan.von.haehling@web.de.
² Division of Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany.

No abstract available

Comment on

Treatment of cachexia: An overview of recent developments.
von Haehling S, Anker SD. von Haehling S, et al. Int J Cardiol. 2015 Apr 1;184:736-742. doi: 10.1016/j.ijcard.2014.10.026. Epub 2014 Oct 16. Int J Cardiol. 2015. PMID: 25804188 Review.
Carnitine for the treatment of cachexia: Lights and shadows.
Molfino A, Amabile MI, Monti M, Rossi Fanelli F, Muscaritoli M. Molfino A, et al. Int J Cardiol. 2015 Nov 1;198:180-1. doi: 10.1016/j.ijcard.2015.06.156. Epub 2015 Jul 2. Int J Cardiol. 2015. PMID: 26163913 No abstract available.